NCT04941859

Brief Summary

This topic in western medicine combined on the basis of gastric lavage therapy in patients with acute poisoning acupoint sticking of traditional Chinese medicine and acupuncture point massage treatment, aims to smoothly accelerate cleaning and discharge poison, increase the poisoning patients rescue success rate, improve patient quality of life, for the clinical treatment of acute poisoning provides a new method of TCM nursing, to further exert TCM nursing characteristics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 18, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 28, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

June 28, 2021

Status Verified

June 1, 2021

Enrollment Period

10 months

First QC Date

June 18, 2021

Last Update Submit

June 18, 2021

Conditions

Keywords

Acute oral intoxicationAcupoint applicationPoint massage

Outcome Measures

Primary Outcomes (3)

  • complications

    Incidence of complications within 24 hours of admission: including nausea, vomiting, and abdominal pain

    one year

  • Time of first bowel movement

    Time of first bowel movement

    through study completion, an average of 1 year

  • patient duration of hospital stay

    patient duration of hospital stay

    through study completion, an average of 1 year

Study Arms (2)

experimental group

EXPERIMENTAL

Patients in the experimental group were treated with acupoint application combined with acupoint massage on the basis of standard treatment for acute poisoning. When the patient began to launder the stomach, the acupoint was applied to Shenque (umbilical). After the end of the gastric launder, Shenque acupoint and Zusanli diarrhea method (referring to counterclockwise and strong stimulation) were massaged for 15 minutes, and the massage frequency was Q8H.

Behavioral: acupoint massage and application

control group

NO INTERVENTION

The treatment plan of control group was carried out according to the diagnosis and treatment standard of acute poisoning.

Interventions

Patients in the experimental group were treated with acupoint application combined with acupoint massage on the basis of standard treatment for acute poisoning. When the patient began to launder the stomach, the acupoint was applied to Shenque (umbilical). After the end of the gastric launder, Shenque acupoint and Zusanli diarrhea method (referring to counterclockwise and strong stimulation) were massaged for 15 minutes, and the massage frequency was Q8H.

experimental group

Eligibility Criteria

Age14 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Patients with oral acute poisoning who were first diagnosed in our hospital and completed gastric lavage;
  • The skin of umbilical cord and bilateral Zusanli acupoints had no injury, scar, rash and other skin diseases.
  • The patient or the patient's family member signed the informed consent and expressed their willingness to receive treatment.

You may not qualify if:

  • Patients with severe conditions requiring cardiopulmonary resuscitation or with severe trauma or multiple injuries;
  • Patients with heart, brain, liver, kidney and hematopoietic system diseases and other serious primary diseases;
  • Patients with a history of gastrointestinal diseases (such as postoperative cancer, intestinal obstruction, and large intestinal polyps) that affect gastrointestinal emptying;
  • Failing to receive treatment according to regulations or taking poison again during hospitalization and unable to judge the curative effect.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hanzhou, Zhejiang, 310000, China

RECRUITING

Study Officials

  • minfei yang

    2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2021

First Posted

June 28, 2021

Study Start

March 8, 2021

Primary Completion

December 31, 2021

Study Completion

December 31, 2021

Last Updated

June 28, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will not share

Locations